TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34050843

Group type: EXPERIMENTAL
Intervention: Long-term residential exposure to air pollution (PM2.5, O3, SO2, NO2, and PM2.5 constituents OC, NH4, NO3, SO4)
Number of subjects: 2681

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched individuals without Hodgkin lymphoma)
Number of subjects: 2681
Study: 32880842

Group type: EXPERIMENTAL
Intervention: MPC + GTO
Number of subjects: 32

Group type: COMPARATOR
Intervention: MPC
Number of subjects: 32
Study: 34427177

Group type: EXPERIMENTAL
Intervention: Inhibitory kinesiotaping (KT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no taping)
Number of subjects: 30
Study: 32826634

Group type: EXPERIMENTAL
Intervention: Resistance (RES) training
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Endurance (END) training
Number of subjects: 84
Study: 32826183

Group type: EXPERIMENTAL
Intervention: Desmopressin MELT
Number of subjects: 130

Group type: COMPARATOR
Intervention: Enuresis alarm
Number of subjects: 130
Study: 36429671

Group type: EXPERIMENTAL
Intervention: Bi-weekly resilience-enhancement program (four 2-h sessions)
Number of subjects: 123
Study: 33964898

Group type: EXPERIMENTAL
Intervention: Nomogram including T stage, N stage, grade, radiotherapy, and chemotherapy
Number of subjects: 6419

Group type: COMPARATOR
Intervention: AJCC 8th staging system
Number of subjects: 6419
Study: 35167386

Group type: EXPERIMENTAL
Intervention: Hip bandage reducing flexion, adduction, and internal rotation of the hip
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 99
Study: 33270193

Group type: EXPERIMENTAL
Intervention: Randomized DNA sequences
Number of subjects: 0
Study: 32017599

Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Need-support condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 40
Study: 36008173

Group type: EXPERIMENTAL
Intervention: Ring External Fixator (Group I)
Number of subjects: 32

Group type: COMPARATOR
Intervention: OssiproÒ gentamicin intramedullary interlocking tibial nail (Group II)
Number of subjects: 32
Study: 34037459

Group type: COMPARATOR
Intervention: Lifestyle education (LS)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Stress reduction guided imagery (SRGI)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Lifestyle behavior guided imagery (LBGI)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 232
Study: 35238796

Group type: EXPERIMENTAL
Intervention: High pressure blood flow restriction
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Moderate pressure blood flow restriction
Number of subjects: 89

Group type: COMPARATOR
Intervention: Sham pressure
Number of subjects: 89
Study: 35143902

Group type: EXPERIMENTAL
Intervention: Cytokine adsorption
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no cytokine adsorption)
Number of subjects: 41
Study: 33426576

Group type: EXPERIMENTAL
Intervention: Living high-training low (LHTL) group (n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Living low-training low (LLTL) group (n=9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 32799180

Group type: EXPERIMENTAL
Intervention: European size 38 clogs (US male size 6½, US female size 7½)
Number of subjects: 50

Group type: COMPARATOR
Intervention: European size 47 clogs (US male size 13½, US female size 14½)
Number of subjects: 50
Study: 35145209

Group type: EXPERIMENTAL
Intervention: High loading dose caffeine (80 mg/kg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard loading dose caffeine (20 mg/kg)
Number of subjects: 74
Study: 33715788

Group type: EXPERIMENTAL
Intervention: Ischemic pressure (IP) with traditional treatment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Postisometric relaxation (PIR) with traditional treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 45
Study: 32929337

Group type: EXPERIMENTAL
Intervention: Macrophage‐biomimetic nanomedicine loaded with rosiglitazone, specific targeting to inflammatory colon, and ROS-responsive release mechanism.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified, but implied standard treatment for UC.
Number of subjects: 0
Study: 36432574

Group type: EXPERIMENTAL
Intervention: Quinoa-enriched wheat-bread roll providing 20 g quinoa flour each day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control wheat-only bread roll
Number of subjects: 28
Study: 34439234

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (10 treatments within five weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Psychoeducation plus insomnia advice booklet (single session)
Number of subjects: 52
Study: 33172720

Group type: EXPERIMENTAL
Intervention: Dupilumab with concomitant topical corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35932644

Group type: EXPERIMENTAL
Intervention: Peer Activate intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison cohort (initiating methadone treatment alone)
Number of subjects: 37
Study: 32584511

Group type: EXPERIMENTAL
Intervention: Sinistral portal hypertension (SPH) in patients with CP
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Risk factors for SPH
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Gastrointestinal bleeding in patients with SPH
Number of subjects: 3358

Group type: COMPARATOR
Intervention: Comparison between bleeding and non-bleeding groups
Number of subjects: 3358
Study: 33730397

Group type: EXPERIMENTAL
Intervention: in‐vivo behavioral skills training (BST)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: interactive computer training (ICT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: video model
Number of subjects: 60
Study: 32506368

Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 65
Study: 34621373

Group type: EXPERIMENTAL
Intervention: Migraine patients (83)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (non-migraine patients)
Number of subjects: 171
Study: 32015261

Group type: EXPERIMENTAL
Intervention: 0.45 mg/d oral conjugated equine estrogens (o-CEE)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: 50 mcg/d transdermal 17β-estradiol (t-E2)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 467
Study: 36373731

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sensory-motor training
Number of subjects: 48
Study: 34092819

Group type: EXPERIMENTAL
Intervention: KIOS software system for managing bipolar disorder
Number of subjects: 20
Study: 33220690

Group type: EXPERIMENTAL
Intervention: Intra-lesional glucantime plus 50% trichloroacetic acid (TCA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intra-lesional glucantime
Number of subjects: 150

Group type: COMPARATOR
Intervention: Systemic glucantime
Number of subjects: 150
Study: 36121699

Group type: EXPERIMENTAL
Intervention: Baseline spiritual well-being
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Increases in spiritual well-being
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Decreases in spiritual well-being
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Marital status (married vs non-married)
Number of subjects: 242
Study: 34184997

Group type: EXPERIMENTAL
Intervention: Digital self-management support tools (DSMSTs)
Number of subjects: 0
Study: 35838863

Group type: EXPERIMENTAL
Intervention: Long-pulsed 755-nm alexandrite laser
Number of subjects: 22
Study: 34114407

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion (HPM)
Number of subjects: 63
Study: 36193494

Group type: EXPERIMENTAL
Intervention: Best Medical Therapy (BMT) combined with Thoracic Endovascular Aortic Repair (TEVAR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (BMT only)
Number of subjects: 90
Study: 32500194

Group type: EXPERIMENTAL
Intervention: Intra-articular facet steroid injection (IFSI)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Transforaminal steroid injection (TFSI)
Number of subjects: 56
Study: 35451239

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 30 minutes after birth
Number of subjects: 68

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 68
Study: 32648476

Group type: EXPERIMENTAL
Intervention: Web-based advance directive (AD)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Paper advance directive (AD)
Number of subjects: 91
Study: 32243719

Group type: EXPERIMENTAL
Intervention: Apple intake (acute intervention, short-term intervention, free-living cohort study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apple intake (dose-response study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary xylose (free-living cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary xylose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control food - broccoli
Number of subjects: 0
Study: 36419383

Group type: EXPERIMENTAL
Intervention: Zhiyang Pingfu Liquid combined with minocycline and methylprednisolone for 14 days
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo liquid combined with minocycline and methylprednisolone for 14 days
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zhiyang Pingfu Liquid
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 58
Study: 35111046

Group type: EXPERIMENTAL
Intervention: High-dose GHX02 (1920 mg/day)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Standard-dose GHX02 (960 mg/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Standard-dose GHX02
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: High-dose GHX02 and Standard-dose GHX02
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: All GHX02 groups
Number of subjects: 117
Study: 34116214

Group type: EXPERIMENTAL
Intervention: PEEK interbody lordotic spacers
Number of subjects: 138

Group type: COMPARATOR
Intervention: Cortical allograft
Number of subjects: 138
Study: 33866196

Group type: EXPERIMENTAL
Intervention: Standard PD therapy
Number of subjects: 106
Study: 35883143

Group type: EXPERIMENTAL
Intervention: APPLE Tree intervention
Number of subjects: 704

Group type: COMPARATOR
Intervention: Control arm (dementia prevention information)
Number of subjects: 704
Study: 33882774

Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous microwave ablation (MWA)
Number of subjects: 234
Study: 32466676

Group type: EXPERIMENTAL
Intervention: MiStent sirolimus-eluting stent
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent
Number of subjects: 1398
Study: 35419610

Group type: EXPERIMENTAL
Intervention: Manipulation under anesthesia (MUA)
Number of subjects: 391

Group type: COMPARATOR
Intervention: No Manipulation under anesthesia (no-MUA)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: MUA patients
Number of subjects: 391
Study: 33244634

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study: 35923135

Group type: EXPERIMENTAL
Intervention: EBP leadership immersion intervention (Cohort 2020)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: EBP leadership immersion intervention (Cohort 2021)
Number of subjects: 66
Study: 32033271

Group type: EXPERIMENTAL
Intervention: Educational intervention via a web-based platform
Number of subjects: 463

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 463
Study: 34348564

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 36472545

Group type: EXPERIMENTAL
Intervention: Oncology nurse-led primary palliative care intervention (CONNECT)
Number of subjects: 235
Study: 34153117

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg once monthly
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 32897933

Group type: EXPERIMENTAL
Intervention: 10 mg prednisolone per day for 1 week
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 35985784

Group type: EXPERIMENTAL
Intervention: Single hamstring tendon graft
Number of subjects: 100

Group type: COMPARATOR
Intervention: Double hamstring tendon graft
Number of subjects: 100
Study: 34593709

Group type: EXPERIMENTAL
Intervention: Patient portal use
Number of subjects: 1081
Study: 32770969

Group type: EXPERIMENTAL
Intervention: Take a Stand! intervention
Number of subjects: 0
Study: 36179790

Group type: EXPERIMENTAL
Intervention: 120-second MicroPulse Transscleral Laser Therapy (MPTLT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 100-second MicroPulse Transscleral Laser Therapy (MPTLT)
Number of subjects: 19
Study: 33073871

Group type: EXPERIMENTAL
Intervention: Mixed-effects regression model based on the hurdle version of the Poisson-Lindley distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian approach based on the Adaptive Metropolis algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis based on standard divergence measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian p-value and randomized quantile residuals
Number of subjects: 0
Study: 32576247

Group type: EXPERIMENTAL
Intervention: Individualized tonotopical fitting of a cochlear implant (CI) based on post-operative cone beam CT scan (CBCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard fitting program
Number of subjects: 20
Study: 35193802

Group type: EXPERIMENTAL
Intervention: Conventional acupressure
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Warm acupressure
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cold acupressure
Number of subjects: 140

Group type: COMPARATOR
Intervention: No acupressure (Control)
Number of subjects: 140
Study: 34656227

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg every 2 weeks)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 32344430

Group type: EXPERIMENTAL
Intervention: Unhealthy drinking habits (binge drinking and excessive consumption)
Number of subjects: 8500

Group type: EXPERIMENTAL
Intervention: Trends in smoking and alcohol consumption
Number of subjects: 8500
Study: 36341778

Group type: EXPERIMENTAL
Intervention: Education provided by rheumatologists
Number of subjects: 102

Group type: COMPARATOR
Intervention: Education provided by nurse specialists
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Multiple switches of bsDMARDs
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Switching from adalimumab bsDMARDs GP2017 to MSB 11022
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Knowledge assessment of bsDMARDs
Number of subjects: 102
Study: 35974020

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt containing Pediococcus acidilactici GR-1
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional yogurt
Number of subjects: 152
Study: 33653126

Group type: EXPERIMENTAL
Intervention: Cleft‐Customized Occlusal Rating system
Number of subjects: 31
Study: 34774080

Group type: EXPERIMENTAL
Intervention: Chinese medicine JCM-16021
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study: 34486432

Group type: EXPERIMENTAL
Intervention: Resistance exercise at 70% of arterial occlusion pressure (high group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No blood flow restriction exercise (control group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Resistance exercise at 40% of arterial occlusion pressure (low group)
Number of subjects: 25
Study: 35438677

Group type: EXPERIMENTAL
Intervention: Physiotherapy + Kinesiotaping (KT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 50
Study: 33866940

Group type: EXPERIMENTAL
Intervention: 2% body mass (BM) shank-positioned wearable resistance (WR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No load (control)
Number of subjects: 15
Study: 34923564

Group type: EXPERIMENTAL
Intervention: Anaesthesia Nociception Index monitoring
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 93
Study: 33359603

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 17
Study: 616597587

Group type: EXPERIMENTAL
Intervention: Body image lessons (6 hours)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (lessons as normal)
Number of subjects: 144
Study: 35298338

Group type: EXPERIMENTAL
Intervention: Technical assistance provided to previously trained producers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABC Cerrado program investment
Number of subjects: 0
Study: 35926833

Group type: EXPERIMENTAL
Intervention: Intranasal (IN) trivalent modified-live virus (MLV) respiratory vaccine with parenteral (PT) bivalent bovine viral diarrhea virus (BVDV) type I + II vaccine (INT)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Parenteral (PT) pentavalent modified-live virus (MLV) respiratory vaccine (INJ)
Number of subjects: 525

Group type: COMPARATOR
Intervention: No MLV respiratory vaccination (CON)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Intranasal (IN) trivalent modified-live virus (MLV) respiratory vaccine with parenteral (PT) BVDV type I + II vaccine (INT)
Number of subjects: 525
Study: 32013965

Group type: EXPERIMENTAL
Intervention: Mobile health applications with high usability problems (based on heuristic evaluation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heuristic evaluation of mobile health applications
Number of subjects: 30
Study: 32405975

Group type: EXPERIMENTAL
Intervention: Sugammadex (2 or 4 mg·kg‐1)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Neostigmine (70 µg·kg‐1, maximum 5 mg)
Number of subjects: 62
Study: 36010858

Group type: EXPERIMENTAL
Intervention: Tip sheet and oral advice
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual oral advice alone
Number of subjects: 280
Study: 33025447

Group type: EXPERIMENTAL
Intervention: Free pharmaceutical services provided in public hospitals
Number of subjects: 797
Study: 33556292

Group type: EXPERIMENTAL
Intervention: Count of all comorbidities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Count of self-management intensive conditions (diabetes, hypertension, congestive heart failure)
Number of subjects: 0
Study: 33952546

Group type: EXPERIMENTAL
Intervention: DHA supplementation (60 mg/kg/day of DHA)
Number of subjects: 955

Group type: COMPARATOR
Intervention: Control emulsion (placebo)
Number of subjects: 955
Study: 33072714

Group type: EXPERIMENTAL
Intervention: Walking in an urban quiet 'green' district (quiet residential area with front gardens and street trees)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Walking in an urban busy 'gray' district (busy, built up commercial street)
Number of subjects: 11
Study: 35605529

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP‐NX)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Extended-release naltrexone (XR‐NTX)
Number of subjects: 570
Study: 33184717

Group type: EXPERIMENTAL
Intervention: Sonic Activation (SA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: No Sonic Activation (NSA)
Number of subjects: 110
Study: 33491385

Group type: EXPERIMENTAL
Intervention: Single application of 1% NaF-HF gel
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Two applications of 1% NaF-HF gel with a 7-day interval
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Two applications of 1% NaF-HF gel with a 6-month interval
Number of subjects: 986

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 986
Study: 32297937

Group type: EXPERIMENTAL
Intervention: Galactose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19

Group type: COMPARATOR
Intervention: Glucose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19

Group type: COMPARATOR
Intervention: Fructose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19
Study: 33196511

Group type: EXPERIMENTAL
Intervention: Anticoagulation and atorvastatin 40 mg daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Anticoagulation alone (with either warfarin or rivaroxaban)
Number of subjects: 21
Study: 34534253

Group type: EXPERIMENTAL
Intervention: Warm-up (walking on a treadmill) followed by a fatiguing exercise (modified sit-to-stand)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control session (sitting on a chair)
Number of subjects: 17
Study: 33050072

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (fish oil emulsion)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Omega-6 fatty acids (sunflower oil emulsion)
Number of subjects: 58
Study: 34431329

Group type: EXPERIMENTAL
Intervention: Real pulsed radiofrequency (PRF) of the saphenous nerve
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham pulsed radiofrequency (PRF) of the saphenous nerve
Number of subjects: 16
Study: 34058488

Group type: EXPERIMENTAL
Intervention: HOBSCOTCH (n=31)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Care-as-usual control (n=20)
Number of subjects: 51
Study: 32423235

Group type: EXPERIMENTAL
Intervention: Listening to music during milking sessions (two sessions of 15 minutes each at 11:00 and 16:00)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Listening to music during milking sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Milking without music (control group)
Number of subjects: 40
Study: 36074799

Group type: EXPERIMENTAL
Intervention: Oligonol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32303884

Group type: EXPERIMENTAL
Intervention: Remimazolam induction at 6 mg kg-1 h-1 (group A)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Remimazolam induction at 12 mg kg-1 h-1 (group B)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Remimazolam maintenance infusion up to 2 mg kg-1 h-1 for both groups
Number of subjects: 67
Study: 35104848

Group type: EXPERIMENTAL
Intervention: Omilancor 440 mg QD
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Omilancor 880 mg QD
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198